A detailed history of Acadian Asset Management LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 426,424 shares of ALXO stock, worth $567,143. This represents 0.0% of its overall portfolio holdings.

Number of Shares
426,424
Holding current value
$567,143
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.81 - $8.13 $771,827 - $3.47 Million
426,424 New
426,424 $773,000
Q2 2022

Aug 09, 2022

BUY
$5.89 - $19.46 $123,424 - $407,784
20,955 New
20,955 $170,000

Others Institutions Holding ALXO

About ALX ONCOLOGY HOLDINGS INC


  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $54.2M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.